{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:48:11Z","timestamp":1790102891273,"version":"4.0.1"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA053159"],"award-info":[{"award-number":["K01DA053159"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG3 DA044831"],"award-info":[{"award-number":["UG3 DA044831"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5UH3DA044798"],"award-info":[{"award-number":["5UH3DA044798"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["4UH3DA044380"],"award-info":[{"award-number":["4UH3DA044380"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UH3DA044823"],"award-info":[{"award-number":["UH3DA044823"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U24DA048538"],"award-info":[{"award-number":["U24DA048538"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5UH3DA044822"],"award-info":[{"award-number":["5UH3DA044822"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["4UH3DA044829-03"],"award-info":[{"award-number":["4UH3DA044829-03"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5UH3DA044822"],"award-info":[{"award-number":["5UH3DA044822"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5UH3DA044826"],"award-info":[{"award-number":["5UH3DA044826"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>Illicitly manufactured fentanyl and its analogs are the primary drivers of opioid overdose deaths in the United States (U.S.). People who use drugs may be exposed to fentanyl or its analogs intentionally or unintentionally. This study sought to identify strategies used by rural people who use drugs to reduce harms associated with unintentional fentanyl exposure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This analysis focused on 349 semi-structured qualitative interviews across 10 states and 58 rural counties in the U.S conducted between 2018 and 2020. Interview guides were collaboratively standardized across sites and included questions about drug use history (including drugs currently used, frequency of use, mode of administration) and questions specific to fentanyl. Deductive coding was used to code all data, then inductive coding of overdose and fentanyl codes was conducted by an interdisciplinary writing team.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Participants described being concerned that fentanyl had saturated the drug market, in both stimulant and opioid supplies. Participants utilized strategies including: (1) avoiding drugs that were perceived to contain fentanyl, (2) buying drugs from trusted sources, (3) using fentanyl test strips, 4) using small doses and non-injection routes, (5) using with other people, (6) tasting, smelling, and looking at drugs before use, and (7) carrying and using naloxone. Most people who used drugs used a combination of these strategies as there was an overwhelming fear of fatal overdose.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>People who use drugs living in rural areas of the U.S. are aware that fentanyl is in their drug supply and use several strategies to prevent associated harms, including fatal overdose. Increasing access to harm reduction tools (e.g., fentanyl test strips, naloxone) and services (e.g., community drug checking, syringe services programs, overdose prevention centers) should be prioritized to address the polysubstance-involved overdose crisis. These efforts should target persons who use opioids and other drugs that may contain fentanyl.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-024-01062-2","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T05:02:20Z","timestamp":1724475740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative"],"prefix":"10.1186","volume":"21","author":[{"given":"Suzan M.","family":"Walters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Fadanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby E.","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Zule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob J.","family":"Fredericksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Bolinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adams L.","family":"Sibley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian F.","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Ouellet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai T.","family":"Pho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Seal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April M.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Stopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,24]]},"reference":[{"key":"1062_CR1","doi-asserted-by":"publisher","unstructured":"Gumas ED, Baumgartner JC. \u201cU.S. Overdose Deaths Remain Higher Than in Other Countries \u2014 How Harm-Reduction Programs Could Help. To the Point (blog), Commonwealth Fund, June 22, 2023. https:\/\/doi.org\/10.26099\/0eb5-9d85","DOI":"10.26099\/0eb5-9d85"},{"key":"1062_CR2","doi-asserted-by":"crossref","unstructured":"Hedegaard H, Mini\u00f1o A, Spencer MR, Warner M. Drug overdose deaths in the United States, 1999\u20132020. NCHS data brief. 2022(428).","DOI":"10.15620\/cdc:112340"},{"issue":"7","key":"1062_CR3","doi-asserted-by":"publisher","first-page":"e2322303","DOI":"10.1001\/jamanetworkopen.2023.22303","volume":"6","author":"T Gomes","year":"2023","unstructured":"Gomes T, Ledlie S, Tadrous M, Mamdani M, Paterson JM, Juurlink DN. Trends in opioid toxicity-related deaths in the US before and after the start of the COVID-19 Pandemic, 2011\u20132021. JAMA Netw Open. 2023;6(7):e2322303.","journal-title":"JAMA Netw Open."},{"key":"1062_CR4","first-page":"1","volume":"457","author":"MR Spencer","year":"2022","unstructured":"Spencer MR, Mini\u00f1o AM, Warner M. Drug overdose deaths in the United States, 2001\u20132021. NCHS Data Brief. 2022;457:1\u20138.","journal-title":"NCHS Data Brief."},{"key":"1062_CR5","unstructured":"Centers for Disease Control and Prevention. National Vital Statistics System. Provisional Drug Overdose Death Counts. Accessed: https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"issue":"4","key":"1062_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","volume":"34","author":"D Ciccarone","year":"2021","unstructured":"Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry. 2021;34(4):344\u201350.","journal-title":"Curr Opin Psychiatry"},{"issue":"17","key":"1062_CR7","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1001\/jama.2018.2844","volume":"319","author":"CM Jones","year":"2018","unstructured":"Jones CM, Einstein EB, Compton WM. Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010\u20132016. JAMA. 2018;319(17):1819.","journal-title":"JAMA."},{"issue":"1","key":"1062_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/ajad.13092","volume":"30","author":"S Martinez","year":"2021","unstructured":"Martinez S, Jones JD, Brandt L, Campbell ANC, Abbott R, Comer SD. The increasing prevalence of fentanyl: a urinalysis-based study among individuals with opioid use disorder in New York City. The American Journal on Addictions. 2021;30(1):65\u201371.","journal-title":"The American Journal on Addictions."},{"issue":"6","key":"1062_CR9","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1080\/10826084.2018.1552303","volume":"54","author":"K McLean","year":"2019","unstructured":"McLean K, Monnat SM, Rigg K, Sterner GE, Verdery A. \u201cYou never know what you\u2019re getting\u201d: opioid users\u2019 perceptions of fentanyl in Southwest Pennsylvania. Subst Use Misuse. 2019;54(6):955\u201366.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"1062_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-019-0311-9","volume":"16","author":"S Rouhani","year":"2019","unstructured":"Rouhani S, Park JN, Morales KB, Green TC, Sherman SG. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence. Harm Reduct J. 2019;16(1):1\u20139.","journal-title":"Harm Reduct J."},{"issue":"12","key":"1062_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.15585\/mmwr.mm6912a1","volume":"69","author":"CM Jones","year":"2020","unstructured":"Jones CM, Compton WM, Mustaquim D. Patterns and characteristics of methamphetamine use among adults\u2014United States, 2015\u20132018. Morb Mortal Wkl Rep. 2020;69(12):317.","journal-title":"Morb Mortal Wkl Rep"},{"key":"1062_CR12","doi-asserted-by":"publisher","first-page":"101184","DOI":"10.1016\/j.pmedr.2020.101184","volume":"20","author":"RL Cooper","year":"2020","unstructured":"Cooper RL, Thompson J, Edgerton R, Watson J, MacMaster SA, Kalliny M, et al. Modeling dynamics of fatal opioid overdose by state and across time. Prev Med Rep. 2020;20:101184.","journal-title":"Prev Med Rep"},{"issue":"3","key":"1062_CR13","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/add.15233","volume":"116","author":"D Furr-Holden","year":"2021","unstructured":"Furr-Holden D, Milam AJ, Wang L, Sadler R. African Americans now outpace whites in opioid-involved overdose deaths: a comparison of temporal trends from 1999 to 2018. Addiction. 2021;116(3):677\u201383.","journal-title":"Addiction"},{"key":"1062_CR14","doi-asserted-by":"publisher","first-page":"106625","DOI":"10.1016\/j.addbeh.2020.106625","volume":"112","author":"M Cano","year":"2021","unstructured":"Cano M. Racial\/ethnic differences in US drug overdose mortality, 2017\u20132018. Addict Behav. 2021;112:106625.","journal-title":"Addict Behav"},{"issue":"29","key":"1062_CR15","doi-asserted-by":"publisher","first-page":"940","DOI":"10.15585\/mmwr.mm7129e2","volume":"71","author":"M Kariisa","year":"2022","unstructured":"Kariisa M, Davis NL, Kumar S, Seth P, Mattson CL, Chowdhury F, et al. Vital signs: drug overdose deaths, by selected sociodemographic and social determinants of health characteristics\u201425 states and the District of Columbia, 2019\u20132020. Morb Mortal Wkl Rep. 2022;71(29):940.","journal-title":"Morb Mortal Wkl Rep"},{"issue":"6","key":"1062_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","volume":"70","author":"CL Mattson","year":"2021","unstructured":"Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and geographic patterns in drug and synthetic opioid overdose deaths\u2014United States, 2013\u20132019. Morb Mortal Wkl Rep. 2021;70(6):202.","journal-title":"Morb Mortal Wkl Rep"},{"issue":"5","key":"1062_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.14485\/HBPR.7.5.11","volume":"7","author":"S Walters","year":"2020","unstructured":"Walters S. COVID-19 and people who use drugs\u2014a commentary. Health Behav Policy Rev. 2020;7(5):489\u201397.","journal-title":"Health Behav Policy Rev"},{"key":"1062_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/jrh.12442","volume":"37","author":"WD Jenkins","year":"2020","unstructured":"Jenkins WD, Bolinski R, Bresett J, Van Ham B, Fletcher S, Walters S, et al. COVID-19 during the opioid epidemic - exacerbation of stigma and vulnerabilities. J Rural Health. 2020;37:172.","journal-title":"J Rural Health."},{"issue":"1","key":"1062_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13722-022-00303-8","volume":"17","author":"SM Walters","year":"2022","unstructured":"Walters SM, Bolinski RS, Almirol E, Grundy S, Fletcher S, Schneider J, et al. Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis. Addict Sci Clin Pract. 2022;17(1):24.","journal-title":"Addict Sci Clin Pract"},{"issue":"4","key":"1062_CR20","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.3390\/ijerph19042230","volume":"19","author":"RS Bolinski","year":"2022","unstructured":"Bolinski RS, Walters S, Salisbury-Afshar E, Ouellet LJ, Jenkins WD, Almirol E, et al. The Impact of the COVID-19 pandemic on drug use behaviors, fentanyl exposure, and harm reduction service support among people who use drugs in rural settings. Int J Environ Res Public Health. 2022;19(4):2230.","journal-title":"Int J Environ Res Public Health."},{"issue":"4","key":"1062_CR21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s11904-018-0406-z","volume":"15","author":"P Mateu-Gelabert","year":"2018","unstructured":"Mateu-Gelabert P, Guarino H, Quinn K, Meylakhs P, Campos S, Meylakhs A, et al. Young drug users: a vulnerable population and an underutilized resource in HIV\/HCV prevention. Curr HIV\/AIDS Rep. 2018;15(4):324\u201335.","journal-title":"Curr HIV\/AIDS Rep."},{"issue":"3","key":"1062_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1080\/17290376.2008.9724913","volume":"5","author":"P Mateu-Gelabert","year":"2008","unstructured":"Mateu-Gelabert P, Bolyard M, Maslow C, Sandoval M, Flom PL, Friedman SR. For the common good: measuring residents\u2019 efforts to protect their community from drug- and sex-related harm. Sahara J. 2008;5(3):144\u201357.","journal-title":"Sahara J."},{"issue":"1","key":"1062_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugpo.2010.06.004","volume":"22","author":"SR Friedman","year":"2011","unstructured":"Friedman SR, Mateu-Gelabert P, Sandoval M. Group sex events amongst non-gay drug users: an understudied risk environment. Int J Drug Policy. 2011;22(1):1\u20138.","journal-title":"Int J Drug Policy."},{"issue":"3","key":"1062_CR24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1521\/aeap.16.3.250.35439","volume":"16","author":"SR Friedman","year":"2004","unstructured":"Friedman SR, Maslow C, Bolyard M, Sandoval M, Mateu-Gelabert P, Neaigus A. Urging others to be healthy: \u201cintravention\u201d by injection drug users as a community prevention goal. AIDS Educ Prev. 2004;16(3):250\u201363.","journal-title":"AIDS Educ Prev."},{"issue":"1","key":"1062_CR25","first-page":"5","volume":"20","author":"SR Friedman","year":"2005","unstructured":"Friedman SR, Bolyard M, Maslow C, Mateu-Gelabert P, Sandoval M. Harnessing the power of social networks to reduce HIV risk. Focus. 2005;20(1):5\u20136.","journal-title":"Focus."},{"issue":"5","key":"1062_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/QAI.0b013e318270d3cb","volume":"61","author":"J Schneider","year":"2012","unstructured":"Schneider J, Michaels S, Bouris A. Family network proportion and HIV risk among black men who have sex with men. J Acquir Immune Defic Syndr. 2012;61(5):627\u201335.","journal-title":"J Acquir Immune Defic Syndr."},{"key":"1062_CR27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.socscimed.2013.12.034","volume":"125","author":"JA Schneider","year":"2015","unstructured":"Schneider JA, Zhou AN, Laumann EO. A new HIV prevention network approach: sociometric peer change agent selection. Soc Sci Med. 2015;125:192\u2013202.","journal-title":"Soc Sci Med."},{"key":"1062_CR28","doi-asserted-by":"publisher","first-page":"102695","DOI":"10.1016\/j.drugpo.2020.102695","volume":"78","author":"JJ Carroll","year":"2020","unstructured":"Carroll JJ, Rich JD, Green TC. The protective effect of trusted dealers against opioid overdose in the US. Int J Drug Policy. 2020;78:102695.","journal-title":"Int J Drug Policy."},{"key":"1062_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109003","volume":"227","author":"AH Kral","year":"2021","unstructured":"Kral AH, Lambdin BH, Browne EN, Wenger LD, Bluthenthal RN, Zibbell JE, et al. Transition from injecting opioids to smoking fentanyl in San Francisco. California Drug and alcohol dependence. 2021;227: 109003.","journal-title":"California. Drug and alcohol dependence."},{"issue":"1","key":"1062_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0232-z","volume":"15","author":"SG Mars","year":"2018","unstructured":"Mars SG, Ondocsin J, Ciccarone D. Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency. Harm Reduct J. 2018;15(1):1\u201310.","journal-title":"Harm Reduct J"},{"key":"1062_CR31","volume-title":"Demand for fentanyl test strips booms\u2014but test is not widely available","author":"B Stewart","year":"2017","unstructured":"Stewart B. Demand for fentanyl test strips booms\u2014but test is not widely available. Toronto: CBC News; 2017."},{"key":"1062_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","volume":"46","author":"D Ciccarone","year":"2017","unstructured":"Ciccarone D. Fentanyl in the US heroin supply: a rapidly changing risk environment. Int J Drug Policy. 2017;46:107.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"1062_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/YCO.0000000000000607","volume":"33","author":"JJ Palamar","year":"2020","unstructured":"Palamar JJ, Salomone A, Barratt MJ. Drug checking to detect fentanyl and new psychoactive substances. Curr Opin Psychiatry. 2020;33(4):301.","journal-title":"Curr Opin Psychiatry"},{"issue":"4","key":"1062_CR34","first-page":"257","volume":"83","author":"N Dasgupta","year":"2022","unstructured":"Dasgupta N. History and future of harm reduction in North Carolina: pragmatism and innovation. N C Med J. 2022;83(4):257\u201360.","journal-title":"N C Med J."},{"issue":"12","key":"1062_CR35","doi-asserted-by":"publisher","first-page":"e22411","DOI":"10.2196\/22411","volume":"4","author":"AS Bennett","year":"2020","unstructured":"Bennett AS, Freeman R, Des Jarlais DC, Aronson ID. Reasons people who use opioids do not accept or carry no-cost naloxone: qualitative interview study. JMIR Formative Res. 2020;4(12):e22411.","journal-title":"JMIR Formative Res"},{"issue":"3","key":"1062_CR36","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0749-3797(01)00349-X","volume":"21","author":"MM Casey","year":"2001","unstructured":"Casey MM, Call KT, Klingner JM. Are rural residents less likely to obtain recommended preventive healthcare services? Am J Prev Med. 2001;21(3):182\u20138.","journal-title":"Am J Prev Med"},{"key":"1062_CR37","doi-asserted-by":"crossref","unstructured":"Ricketts TC, Johnson-Webb KD, Randolph RK. Populations and places in rural America. Rural Health United States. 1999:7\u201324.","DOI":"10.1093\/oso\/9780195131284.003.0002"},{"key":"1062_CR38","doi-asserted-by":"crossref","unstructured":"Schur CL, Franco SJ. Access to health care. Rural health in the United States. 1999:25\u201337.","DOI":"10.1093\/oso\/9780195131284.003.0003"},{"issue":"3","key":"1062_CR39","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.healthplace.2008.12.007","volume":"15","author":"JN Laditka","year":"2009","unstructured":"Laditka JN, Laditka SB, Probst JC. Health care access in rural areas: evidence that hospitalization for ambulatory care-sensitive conditions in the United States may increase with the level of rurality. Health Place. 2009;15(3):731\u201340.","journal-title":"Health Place."},{"key":"1062_CR40","unstructured":"Meit M, Knudson A, Gilbert T, Yu AT-C, Tanenbaum E, Ormson E, et al. The 2014 update of the rural-urban chartbook. Bethesda, MD: Rural Health Reform Policy Research Center. 2014."},{"issue":"3","key":"1062_CR41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11904-018-0393-0","volume":"15","author":"AJ Schranz","year":"2018","unstructured":"Schranz AJ, Barrett J, Hurt CB, Malvestutto C, Miller WC. Challenges facing a rural opioid epidemic: treatment and prevention of HIV and hepatitis C. Curr HIV\/Aids Rep. 2018;15(3):245\u201354.","journal-title":"Curr HIV\/Aids Rep"},{"issue":"3","key":"1062_CR42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/2150131914560229","volume":"6","author":"RP Westergaard","year":"2015","unstructured":"Westergaard RP, Stockman LJ, Hyland HA, Guilfoyle SM, Fangman JJ, Vergeront JM. Provider workforce assessment in a rural hepatitis C epidemic: implications for scale-up of antiviral therapy. J Prim Care Community Health. 2015;6(3):215\u20137.","journal-title":"J Prim Care Community Health."},{"issue":"1","key":"1062_CR43","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/jrh.12129","volume":"32","author":"T Browne","year":"2016","unstructured":"Browne T, Priester MA, Clone S, Iachini A, DeHart D, Hock R. Barriers and facilitators to substance use treatment in the rural south: a qualitative study. J Rural Health. 2016;32(1):92\u2013101.","journal-title":"J Rural Health"},{"issue":"6","key":"1062_CR44","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/tbm\/ibz129","volume":"9","author":"R Bolinski","year":"2019","unstructured":"Bolinski R, Ellis K, Zahnd WE, Walters S, McLuckie C, Schneider J, et al. Social norms associated with nonmedical opioid use in rural communities: a systematic review. Transl Behav Med. 2019;9(6):1224\u201332.","journal-title":"Transl Behav Med"},{"key":"1062_CR45","doi-asserted-by":"publisher","first-page":"593925","DOI":"10.3389\/fsoc.2020.593925","volume":"5","author":"K Ellis","year":"2020","unstructured":"Ellis K, Walters S, Friedman S, Ouellet L, Ezell J, Rosentel K, et al. Breaching trust: a qualitative study of healthcare experiences of people who use drugs in a rural setting. Front Sociol. 2020;5:593925. https:\/\/doi.org\/10.3389\/fsoc.2020.593925.","journal-title":"Front Sociol"},{"key":"1062_CR46","doi-asserted-by":"publisher","first-page":"113470","DOI":"10.1016\/j.socscimed.2020.113470","volume":"268","author":"JM Ezell","year":"2021","unstructured":"Ezell JM, Walters S, Friedman SR, Bolinski R, Jenkins WD, Schneider J, et al. Stigmatize the use, not the user? Attitudes on opioid use, drug injection, treatment, and overdose prevention in rural communities. Soc Sci Med. 2021;268:113470.","journal-title":"Soc Sci Med"},{"key":"1062_CR47","doi-asserted-by":"crossref","unstructured":"Walters SM, Frank D, Van Ham B, Jaiswal J, Muncan B, Earnshaw V, et al. PrEP care continuum engagement among persons who inject drugs: rural and urban differences in stigma and social infrastructure. AIDS Behav. 2021:1\u201313.","DOI":"10.1007\/s10461-021-03488-2"},{"key":"1062_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.drugpo.2017.03.013","volume":"44","author":"GE Nagelhout","year":"2017","unstructured":"Nagelhout GE, Hummel K, de Goeij MC, de Vries H, Kaner E, Lemmens P. How economic recessions and unemployment affect illegal drug use: a systematic realist literature review. Int J Drug Policy. 2017;44:69\u201383.","journal-title":"Int J Drug Policy"},{"key":"1062_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jhealeco.2016.12.009","volume":"52","author":"CS Carpenter","year":"2017","unstructured":"Carpenter CS, McClellan CB, Rees DI. Economic conditions, illicit drug use, and substance use disorders in the United States. J Health Econ. 2017;52:63\u201373.","journal-title":"J Health Econ"},{"key":"1062_CR50","first-page":"193","volume-title":"Risk environments and drug harms: a social science for harm reduction approach","author":"T Rhodes","year":"2009","unstructured":"Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Amsterdam: Elsevier; 2009. p. 193\u2013201."},{"key":"1062_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-017-0196-4","volume":"14","author":"M Hawk","year":"2017","unstructured":"Hawk M, Coulter RW, Egan JE, Fisk S, Reuel Friedman M, Tula M, et al. Harm reduction principles for healthcare settings. Harm Reduct J. 2017;14:1\u20139.","journal-title":"Harm Reduct J"},{"key":"1062_CR52","unstructured":"Albers E. Harm reduction: contribution to a critical appraisal from the perspective of people who use drugs. Harm Reduct Subst Use High-Risk Behav Int Policy Pract. 2012:124\u201331."},{"key":"1062_CR53","unstructured":"Coalition NHR. Principles of harm reduction. 2020."},{"issue":"2","key":"1062_CR54","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugpo.2006.11.006","volume":"18","author":"SR Friedman","year":"2007","unstructured":"Friedman SR, de Jong W, Rossi D, Touz\u00e9 G, Rockwell R, Des Jarlais DC, et al. Harm reduction theory: users\u2019 culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users\u2019 groups. Int J Drug Policy. 2007;18(2):107\u201317.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"1062_CR55","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/j.drugpo.2012.10.003","volume":"24","author":"M Harris","year":"2013","unstructured":"Harris M, Rhodes T. Methadone diversion as a protective strategy: the harm reduction potential of \u2018generous constraints.\u2019 Int J Drug Policy. 2013;24(6):e43\u201350.","journal-title":"Int J Drug Policy"},{"issue":"5","key":"1062_CR56","doi-asserted-by":"publisher","first-page":"774","DOI":"10.2105\/AJPH.91.5.774","volume":"91","author":"MW Langendam","year":"2001","unstructured":"Langendam MW, van Brussel GH, Coutinho RA, Van Ameijden E. The impact of harm-reduction-based methadone treatment on mortality among heroin users. Am J Public Health. 2001;91(5):774.","journal-title":"Am J Public Health"},{"issue":"6","key":"1062_CR57","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/0306-4603(96)00042-1","volume":"21","author":"GA Marlatt","year":"1996","unstructured":"Marlatt GA. Harm reduction: come as you are. Addict Behav. 1996;21(6):779\u201388.","journal-title":"Addict Behav."},{"key":"1062_CR58","doi-asserted-by":"publisher","first-page":"102751","DOI":"10.1016\/j.drugpo.2020.102751","volume":"79","author":"S Parkin","year":"2020","unstructured":"Parkin S, Neale J, Brown C, Campbell AN, Castillo F, Jones JD, et al. Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative study. Int J Drug Policy. 2020;79:102751.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1062_CR59","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10615-016-0584-3","volume":"45","author":"SP Vakharia","year":"2017","unstructured":"Vakharia SP, Little J. Starting where the client is: harm reduction guidelines for clinical social work practice. Clin Soc Work J. 2017;45(1):65\u201376.","journal-title":"Clin Soc Work J."},{"issue":"2","key":"1062_CR60","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11524-023-00717-y","volume":"100","author":"RE Giglio","year":"2023","unstructured":"Giglio RE, Mantha S, Harocopos A, Saha N, Reilly J, Cipriano C, et al. The Nation\u2019s first publicly recognized overdose prevention centers: lessons learned in New York City. J Urban Health. 2023;100(2):245\u201354.","journal-title":"J Urban Health"},{"issue":"9775","key":"1062_CR61","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","volume":"377","author":"BD Marshall","year":"2011","unstructured":"Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: a retrospective population-based study. The Lancet. 2011;377(9775):1429\u201337.","journal-title":"The Lancet."},{"key":"1062_CR62","doi-asserted-by":"publisher","first-page":"102845","DOI":"10.1016\/j.drugpo.2020.102845","volume":"87","author":"A Betsos","year":"2021","unstructured":"Betsos A, Valleriani J, Boyd J, Bardwell G, Kerr T, McNeil R. \u201cI couldn\u2019t live with killing one of my friends or anybody\u201d: a rapid ethnographic study of drug sellers\u2019 use of drug checking. Int J Drug Policy. 2021;87:102845.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1062_CR63","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1186\/s12889-021-11243-4","volume":"21","author":"B Wallace","year":"2021","unstructured":"Wallace B, Van Roode T, Pagan F, Hore D, Pauly B. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users. BMC Public Health. 2021;21(1):1156.","journal-title":"BMC Public Health."},{"issue":"1","key":"1062_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-020-00399-8","volume":"17","author":"B Muncan","year":"2020","unstructured":"Muncan B, Walters SM, Ezell J, Ompad DC. \u201cThey look at us like junkies\u201d: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J. 2020;17(1):1\u20139.","journal-title":"Harm Reduct J"},{"issue":"2","key":"1062_CR65","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/09581596.2011.611487","volume":"22","author":"CB Smith","year":"2012","unstructured":"Smith CB. Harm reduction as anarchist practice: a user\u2019s guide to capitalism and addiction in North America. Crit Public Health. 2012;22(2):209\u201321.","journal-title":"Crit Public Health"},{"key":"1062_CR66","unstructured":"Szott K. Expanding the mission of harm reduction: a public health population and its members\u2019 perspectives towards health. Critical approaches to harm reduction: conflict, institutionalization,(de-) politicization, and direct action, edited by Christopher BR Smith and Zack Marshall. 2016;169:84."},{"key":"1062_CR67","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/jcop.22581","volume":"50","author":"SR Friedman","year":"2021","unstructured":"Friedman SR, Williams LD, Guarino H, Mateu-Gelabert P, Krawczyk N, Hamilton L, et al. The stigma system: how sociopolitical domination, scapegoating, and stigma shape public health. J Commun Psychol. 2021;50:385\u2013408.","journal-title":"J Commun Psychol"},{"issue":"3","key":"1062_CR68","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2105\/AJPH.2005.065961","volume":"97","author":"B Tempalski","year":"2007","unstructured":"Tempalski B, Flom PL, Friedman SR, Des Jarlais DC, Friedman JJ, McKnight C, et al. Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas. Am J Public Health. 2007;97(3):437\u201347.","journal-title":"Am J Public Health"},{"issue":"5","key":"1062_CR69","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1080\/10826084.2021.1892142","volume":"56","author":"B Muncan","year":"2021","unstructured":"Muncan B, Jordan AE, Perlman DC, Frank D, Ompad DC, Walters SM. Acceptability and effectiveness of hepatitis C care at syringe service programs for people who inject drugs in New York City. Subst Use Misuse. 2021;56(5):728\u201337.","journal-title":"Subst Use Misuse."},{"issue":"2","key":"1062_CR70","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3390\/ijerph20021648","volume":"20","author":"SM Walters","year":"2023","unstructured":"Walters SM, Felsher M, Frank D, Jaiswal J, Townsend T, Muncan B, et al. I don\u2019t believe a person has to die when trying to get high: overdose prevention and response strategies in rural Illinois. Int J Environ Res Public Health. 2023;20(2):1648.","journal-title":"Int J Environ Res Public Health."},{"key":"1062_CR71","doi-asserted-by":"publisher","first-page":"103146","DOI":"10.1016\/j.drugpo.2021.103146","volume":"92","author":"T Antoniou","year":"2021","unstructured":"Antoniou T, Pritlove C, Shearer D, Martins D, Tadrous M, Munro C, et al. A qualitative study of a publicly funded pharmacy-dispensed naloxone program. Int J Drug Policy. 2021;92:103146.","journal-title":"Int J Drug Policy"},{"key":"1062_CR72","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.trsl.2021.03.001","volume":"234","author":"AS Bennett","year":"2021","unstructured":"Bennett AS, Elliott L. Naloxone\u2019s role in the national opioid crisis\u2014past struggles, current efforts, and future opportunities. Transl Res. 2021;234:43\u201357.","journal-title":"Transl Res"},{"issue":"1","key":"1062_CR73","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13722-022-00322-5","volume":"17","author":"RA Jenkins","year":"2022","unstructured":"Jenkins RA, Whitney BM, Nance RM, Allen TM, Cooper HLF, Feinberg J, et al. The rural opioid initiative consortium description: providing evidence to understand the fourth wave of the opioid crisis. Addict Sci Clin Pract. 2022;17(1):38.","journal-title":"Addict Sci Clin Pract"},{"issue":"3","key":"1062_CR74","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/QAI.0000000000001098","volume":"73","author":"MM Van Handel","year":"2016","unstructured":"Van Handel MM, Rose CE, Hallisey EJ, Kolling JL, Zibbell JE, Lewis B, et al. County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. J Acquir Immune Defic Syndr. 2016;73(3):323\u201331.","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"11","key":"1062_CR75","doi-asserted-by":"publisher","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","volume":"69","author":"N Wilson","year":"2020","unstructured":"Wilson N, Kariisa M, Seth P, Smith H, Davis NL. Drug and opioid-involved overdose deaths - United States, 2017\u20132018. MMWR Morb Mortal Wkly Rep. 2020;69(11):290\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"1","key":"1062_CR76","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1370\/afm.1735","volume":"13","author":"RA Rosenblatt","year":"2015","unstructured":"Rosenblatt RA, Andrilla CH, Catlin M, Larson EH. Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Ann Fam Med. 2015;13(1):23\u20136.","journal-title":"Ann Fam Med."},{"issue":"6","key":"1062_CR77","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1177\/0033354920954796","volume":"135","author":"AM Young","year":"2020","unstructured":"Young AM, Ballard AM, Cooper HLF. Novel recruitment methods for research among young adults in rural areas who use opioids: cookouts, coupons, and community-based staff. Public Health Rep. 2020;135(6):746\u201355.","journal-title":"Public Health Rep"},{"key":"1062_CR78","doi-asserted-by":"crossref","unstructured":"Charmaz K, Belgrave LL. Grounded theory. The Blackwell encyclopedia of sociology. 2007.","DOI":"10.1002\/9781405165518.wbeosg070"},{"issue":"2","key":"1062_CR79","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"issue":"1","key":"1062_CR80","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/epirev\/mxaa011","volume":"42","author":"CM Jones","year":"2020","unstructured":"Jones CM, Bekheet F, Park JN, Alexander GC. The evolving overdose epidemic: synthetic opioids and rising stimulant-related harms. Epidemiol Rev. 2020;42(1):154\u201366.","journal-title":"Epidemiol Rev"},{"issue":"4","key":"1062_CR81","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","volume":"34","author":"D Ciccarone","year":"2021","unstructured":"Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry. 2021;34(4):344\u201350.","journal-title":"Curr Opin Psychiatry."},{"issue":"8","key":"1062_CR82","doi-asserted-by":"publisher","first-page":"e2226544","DOI":"10.1001\/jamanetworkopen.2022.26544","volume":"5","author":"PT Korthuis","year":"2022","unstructured":"Korthuis PT, Cook RR, Foot CA, Leichtling G, Tsui JI, Stopka TJ, et al. Association of methamphetamine and opioid use with nonfatal overdose in rural communities. JAMA Netw Open. 2022;5(8):e2226544.","journal-title":"JAMA Netw Open."},{"issue":"50","key":"1062_CR83","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.15585\/mmwr.mm7050e3","volume":"70","author":"J O\u2019Donnell","year":"2021","unstructured":"O\u2019Donnell J, Tanz LJ, Gladden RM, Davis NL, Bitting J. Trends in and characteristics of drug overdose deaths involving illicitly manufactured fentanyls\u2014United States, 2019\u20132020. Morb Mortal Wkl Rep. 2021;70(50):1740.","journal-title":"Morb Mortal Wkl Rep"},{"issue":"1","key":"1062_CR84","doi-asserted-by":"publisher","first-page":"e1918514","DOI":"10.1001\/jamanetworkopen.2019.18514","volume":"3","author":"RK Twillman","year":"2020","unstructured":"Twillman RK, Dawson E, LaRue L, Guevara MG, Whitley P, Huskey A. Evaluation of trends of near-real-time urine drug test results for methamphetamine, cocaine, heroin, and fentanyl. JAMA Netw Open. 2020;3(1):e1918514.","journal-title":"JAMA Netw Open."},{"issue":"8","key":"1062_CR85","doi-asserted-by":"publisher","first-page":"e2226544","DOI":"10.1001\/jamanetworkopen.2022.26544","volume":"5","author":"PT Korthuis","year":"2022","unstructured":"Korthuis PT, Cook RR, Foot CA, Leichtling G, Tsui JI, Stopka TJ, et al. Association of methamphetamine and opioid use with nonfatal overdose in rural communities. JAMA Netw Open. 2022;5(8):e2226544.","journal-title":"JAMA Netw Open"},{"key":"1062_CR86","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.drugpo.2017.06.004","volume":"46","author":"D Ciccarone","year":"2017","unstructured":"Ciccarone D, Ondocsin J, Mars SG. Heroin uncertainties: Exploring users\u2019 perceptions of fentanyl-adulterated and -substituted \u2018heroin.\u2019 Int J Drug Policy. 2017;46:146\u201355.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"1062_CR87","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/02791072.2017.1394508","volume":"50","author":"SG Mars","year":"2018","unstructured":"Mars SG, Ondocsin J, Ciccarone D. Sold as heroin: perceptions and use of an evolving drug in Baltimore, MD. J Psychoact . 2018;50(2):167\u201376.","journal-title":"J Psychoact ."},{"key":"1062_CR88","doi-asserted-by":"publisher","first-page":"102671","DOI":"10.1016\/j.drugpo.2020.102671","volume":"77","author":"SM Walters","year":"2020","unstructured":"Walters SM, Coston B, Neaigus A, Rivera AV, Starbuck L, Ramirez V, et al. The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs. Int J Drug Policy. 2020;77:102671.","journal-title":"Int J Drug Policy."},{"issue":"1","key":"1062_CR89","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12954-017-0166-x","volume":"14","author":"SM Walters","year":"2017","unstructured":"Walters SM, Reilly KH, Neaigus A, Braunstein S. Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention. Harm Reduct J. 2017;14(1):40.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1062_CR90","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3818\/JRP.13.1.2011.23","volume":"13","author":"AS Bennett","year":"2011","unstructured":"Bennett AS, Golub A, Dunlap E. Drug market reconstitution after Hurricane Katrina: lessons for local drug abuse control initiatives. Just Res Policy. 2011;13(1):23\u201344.","journal-title":"Just Res Policy"},{"issue":"2","key":"1062_CR91","doi-asserted-by":"publisher","first-page":"e001170","DOI":"10.1136\/bmjoq-2020-001170","volume":"10","author":"J Agley","year":"2021","unstructured":"Agley J, Henderson C, Adams Z, Hulvershorn L. Provider engagement in Indiana\u2019s opioid use disorder ECHO programme: there is a will but not always a way. BMJ Open Qual. 2021;10(2):e001170.","journal-title":"BMJ Open Qual"},{"issue":"7","key":"1062_CR92","doi-asserted-by":"publisher","first-page":"708","DOI":"10.2105\/AJPH.2023.307329","volume":"113","author":"N Dasgupta","year":"2023","unstructured":"Dasgupta N. We can\u2019t arrest our way out of overdose: the drug bust paradox. Am J Public Health. 2023;113(7):708.","journal-title":"Am J Public Health"},{"issue":"7","key":"1062_CR93","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2105\/AJPH.2023.307291","volume":"113","author":"B Ray","year":"2023","unstructured":"Ray B, Korzeniewski SJ, Mohler G, Carroll JJ, Del Pozo B, Victor G, et al. Spatiotemporal analysis exploring the effect of law enforcement drug market disruptions on overdose, Indianapolis, Indiana, 2020\u20132021. Am J Public Health. 2023;113(7):750\u20138.","journal-title":"Am J Public Health."},{"issue":"4","key":"1062_CR94","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1086\/604215","volume":"70","author":"N Gerstel","year":"1996","unstructured":"Gerstel N, Bogard CJ, McConnell JJ, Schwartz M. The therapeutic incarceration of homeless families. Soc Serv Rev. 1996;70(4):543\u201372.","journal-title":"Soc Serv Rev"},{"issue":"12","key":"1062_CR95","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1080\/10826084.2023.2231067","volume":"58","author":"C Santelices","year":"2023","unstructured":"Santelices C, Matsumoto A, Boulad M, Stopka TJ. Evaluating technologies to identify fentanyl and adulterants in street drug paraphernalia: qualitative perspectives of service providers and their clientele. Subst Use Misuse. 2023;58(12):1528\u201335.","journal-title":"Subst Use Misuse."},{"key":"1062_CR96","doi-asserted-by":"crossref","unstructured":"Allen ST, O\u2019Rourke A, White RH, Sherman SG, Grieb SM. Perspectives on fentanyl test strip use among people who inject drugs in rural appalachia. Subst Use Misuse. 2020:1\u20137.","DOI":"10.1080\/10826084.2020.1753773"},{"key":"1062_CR97","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.drugpo.2018.08.004","volume":"60","author":"C McKnight","year":"2018","unstructured":"McKnight C, Des Jarlais DC. Being \u201chooked up\u201d during a sharp increase in the availability of illicitly manufactured fentanyl: Adaptations of drug using practices among people who use drugs (PWUD) in New York City. Int J Drug Policy. 2018;60:82\u20138.","journal-title":"Int J Drug Policy"},{"key":"1062_CR98","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drugpo.2018.08.007","volume":"63","author":"NC Peiper","year":"2019","unstructured":"Peiper NC, Clarke SD, Vincent LB, Ciccarone D, Kral AH, Zibbell JE. Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the Southeastern United States. Int J Drug Policy. 2019;63:122\u20138.","journal-title":"Int J Drug Policy"},{"key":"1062_CR99","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.drugalcdep.2018.09.006","volume":"193","author":"S Mayer","year":"2018","unstructured":"Mayer S, Boyd J, Collins A, Kennedy MC, Fairbairn N, McNeil R. Characterizing fentanyl-related overdoses and implications for overdose response: findings from a rapid ethnographic study in Vancouver, Canada. Drug Alcohol Depend. 2018;193:69\u201374.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1062_CR100","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12954-021-00530-3","volume":"18","author":"M Perri","year":"2021","unstructured":"Perri M, Kaminski N, Bonn M, Kolla G, Guta A, Bayoumi AM, et al. A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone. Harm Reduct J. 2021;18(1):85.","journal-title":"Harm Reduct J"},{"key":"1062_CR101","doi-asserted-by":"publisher","first-page":"100541","DOI":"10.1016\/j.sste.2022.100541","volume":"43","author":"J Pustz","year":"2022","unstructured":"Pustz J, Srinivasan S, Larochelle MR, Walley AY, Stopka TJ. Relationships between places of residence, injury, and death: Spatial and statistical analysis of fatal opioid overdoses across Massachusetts. Spat Spatiotemporal Epidemiol. 2022;43:100541.","journal-title":"Spat Spatiotemporal Epidemiol."},{"issue":"1","key":"1062_CR102","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12954-022-00670-0","volume":"19","author":"K Ritchie","year":"2022","unstructured":"Ritchie K, Ghosh SM. Determining the feasibility for an overdose prevention line to support substance users who use alone. Harm Reduction Journal. 2022;19(1):92.","journal-title":"Harm Reduction Journal."},{"key":"1062_CR103","doi-asserted-by":"publisher","first-page":"103147","DOI":"10.1016\/j.drugpo.2021.103147","volume":"92","author":"MK Reed","year":"2021","unstructured":"Reed MK, Roth AM, Tabb LP, Groves AK, Lankenau SE. \u201cI probably got a minute\u201d: perceptions of fentanyl test strip use among people who use stimulants. Int J Drug Policy. 2021;92:103147.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"1062_CR104","doi-asserted-by":"publisher","first-page":"S168","DOI":"10.1016\/j.japh.2017.01.022","volume":"57","author":"EM Oliva","year":"2017","unstructured":"Oliva EM, Christopher MLD, Wells D, Bounthavong M, Harvey M, Himstreet J, et al. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration\u2019s national program. J Am Pharm Assoc. 2017;57(2):S168\u201379.","journal-title":"J Am Pharm Assoc."},{"key":"1062_CR105","unstructured":"Klinenberg E. Palaces for the people: how social infrastructure can help fight inequality, polarization, and the decline of civic life. Crown; 2018."},{"issue":"1","key":"1062_CR106","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12954-022-00590-z","volume":"19","author":"JJ Carroll","year":"2022","unstructured":"Carroll JJ, Mackin S, Schmidt C, McKenzie M, Green TC. The Bronze Age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19. Harm Reduct J. 2022;19(1):9.","journal-title":"Harm Reduct J"},{"issue":"2","key":"1062_CR107","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/aje\/kwab233","volume":"191","author":"N Dasgupta","year":"2021","unstructured":"Dasgupta N, Figgatt MC. Invited commentary: drug checking for novel insights into the unregulated drug supply. Am J Epidemiol. 2021;191(2):248\u201352.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"1062_CR108","first-page":"e28160","volume":"14","author":"SV Malayala","year":"2022","unstructured":"Malayala SV, Papudesi BN, Bobb R, Wimbush A. Xylazine-induced skin ulcers in a person who injects drugs in Philadelphia, Pennsylvania, USA. Cureus. 2022;14(8):e28160.","journal-title":"Cureus."},{"issue":"8","key":"1062_CR109","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.2105\/AJPH.2022.306881","volume":"112","author":"RS Alexander","year":"2022","unstructured":"Alexander RS, Canver BR, Sue KL, Morford KL. Xylazine and overdoses: trends, concerns, and recommendations. Am J Public Health. 2022;112(8):1212\u20136.","journal-title":"Am J Public Health"},{"key":"1062_CR110","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cca.2021.07.010","volume":"521","author":"WR Korn","year":"2021","unstructured":"Korn WR, Stone MD, Haviland KL, Toohey JM, Stickle DF. High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021. Clin Chim Acta. 2021;521:151\u20134.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"1062_CR111","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/jrh.12660","volume":"39","author":"K Nolte","year":"2023","unstructured":"Nolte K, Romo E, Stopka TJ, Drew A, Dowd P, Del Toro-Mejias L, et al. \u201cI\u2019ve been to more of my friends\u2019 funerals than I\u2019ve been to my friends\u2019 weddings\u201d: witnessing and responding to overdose in rural Northern New England. J Rural Health. 2023;39(1):197\u2013211.","journal-title":"J Rural Health"},{"key":"1062_CR112","doi-asserted-by":"crossref","unstructured":"Doe-Simkins M, Wheeler EJ, Figgatt MC, Jones TS, Bell A, Davidson PJ, et al. Naloxone buyers club: overlooked critical public health infrastructure for preventing overdose deaths. medRxiv. 2021:2021.11.14.21266221.","DOI":"10.1101\/2021.11.14.21266221"},{"key":"1062_CR113","doi-asserted-by":"crossref","unstructured":"Walters SM, Kerr J, Cano M, Earnshaw V, Link B. Intersectional stigma as a fundamental cause of health disparities: a case study of how drug use stigma intersecting with racism and xenophobia creates health inequities for Black and Hispanic persons who use drugs over time. Stigma Health. 2023.","DOI":"10.1037\/sah0000426"},{"issue":"14","key":"1062_CR114","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1001\/jama.2022.2847","volume":"327","author":"J Friedman","year":"2022","unstructured":"Friedman J, Godvin M, Shover CL, Gone JP, Hansen H, Schriger DL. Trends in drug overdose deaths among US Adolescents, January 2010 to June 2021. JAMA. 2022;327(14):1398\u2013400.","journal-title":"JAMA."},{"key":"1062_CR115","first-page":"222","volume":"84","author":"D Frank","year":"2023","unstructured":"Frank D, Krawczyk N, Arshonsky J, Bragg MA, Friedman SR, Bunting AM. Covid-19-related changes to drug-selling networks and their effects on people who use illicit opioids. J Stud Alcohol Drugs. 2023;84:222\u20139.","journal-title":"J Stud Alcohol Drugs"},{"issue":"3","key":"1062_CR116","first-page":"193","volume":"20","author":"T Rhodes","year":"2009","unstructured":"Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Risk Environ Drug Harms. 2009;20(3):193\u2013201.","journal-title":"Risk Environ Drug Harms"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-01062-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-024-01062-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-01062-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T06:03:50Z","timestamp":1724479430000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-024-01062-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,24]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1062"],"URL":"https:\/\/doi.org\/10.1186\/s12954-024-01062-2","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,24]]},"assertion":[{"value":"15 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}